Mydecine Innovations Group Inc (MYCO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14 | 20 | 38 | 17 | 40 |
| Receivables | 145 | 174 | 155 | 101 | 123 |
| TOTAL | $159 | $213 | $212 | $3,963 | $564 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 0 | 0 | 1 |
| Other Non-Current Assets | 0 | 0 | 0 | 491 | 460 |
| TOTAL | $0 | $0 | $0 | $491 | $461 |
| Total Assets | $159 | $213 | $212 | $4,454 | $1,025 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,144 | 5,776 | 5,423 | 88 | 85 |
| Accounts payable and accrued liabilities | 9,329 | 7,136 | 6,564 | 5,122 | 4,647 |
| Accrued Expenses | 140 | 140 | 140 | 346 | 208 |
| TOTAL | $15,613 | $13,053 | $12,128 | $5,556 | $4,940 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 5,415 | 5,170 |
| TOTAL | $0 | $0 | $0 | $5,415 | $5,170 |
| Total Liabilities | $15,613 | $13,053 | $12,128 | $10,972 | $10,110 |
| Shareholders' Equity | |||||
| Common Shares | 126,269 | 126,215 | 126,123 | 125,019 | 121,269 |
| Retained earnings | -158,797 | -156,128 | -155,112 | -148,500 | -147,317 |
| Other shareholders' equity | 286 | 286 | 286 | 176 | 176 |
| TOTAL | $-15,454 | $-12,839 | $-11,915 | $-6,518 | $-9,085 |
| Total Liabilities And Equity | $159 | $213 | $212 | $4,454 | $1,025 |